SC
BBIO icon

SouthState Corp’s BridgeBio Pharma BBIO Stock Holding History

SouthState Corp’s Portfolio BBIO Stock Details BBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.19K Hold
16
– – ﹤0.01% 1073
2026
Q1 		$1.19K Hold
16
– – ﹤0.01% 1006
2025
Q4 		$1.22K Hold
16
– – ﹤0.01% 1081
2025
Q3 		$832 Hold
16
– – ﹤0.01% 1110
2025
Q2 		$691 Sell
16
-14
-47% -$509 ﹤0.01% 1358
2025
Q1 		$1.04K Buy
+30
New +$1.01K ﹤0.01% 1328

Other funds holding BBIO

JT
Jupiter Topco New York $245B AUM
KKRC
Kohlberg Kravis Roberts & Co New York $5.71B AUM 72.37% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
ACM
Aisling Capital Management New York $472M AUM 106.83% 1-Year Est. Return

SouthState Corp's BBIO Position: Q2 2026 in Review

SouthState Corp held its BridgeBio Pharma (BBIO) position steady in Q2 2026 at 16 shares worth $1.19K. The position accounts for ﹤0.01% of the portfolio, ranked #1073.

SouthState Corp first reported a position in BBIO in Q1 2025 and has held it in 6 quarters since. The position peaked at $1.22K in Q4 2025. 474 funds tracked by Wall St. Rank hold BBIO as of Q2 2026.

  • SouthState Corp held 16 shares of BridgeBio Pharma worth $1.19K as of Q2 2026.
  • SouthState Corp left its BridgeBio Pharma share count unchanged in Q2 2026.
  • BridgeBio Pharma made up ﹤0.01% of SouthState Corp's portfolio in Q2 2026, its #1073 holding.
  • SouthState Corp first reported a position in BridgeBio Pharma in Q1 2025 and has held it in 6 quarters since.
  • SouthState Corp's BridgeBio Pharma position peaked at $1.22K in Q4 2025.
  • 474 funds tracked by Wall St. Rank held BridgeBio Pharma as of Q2 2026.

Based on SouthState Corp's 13F filing for Q2 2026, filed 6 Aug 2026.